Skip to content
10-Q

Quarterly Report

Korro Bio, Inc. KRRO

0000950170-25-065800

← back to feed
Filed
May 7, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 5, 2025 9.39M sh
Cash And Equivalents Q1 2025 · Mar 31, 2025 $64.14M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $55.64M
Current Liabilities Q1 2025 · Mar 31, 2025 $12.88M
Current Liabilities Q1 2025 · Dec 31, 2024 $14.96M
Total Liabilities Q1 2025 · Mar 31, 2025 $63.25M
Total Liabilities Q1 2025 · Dec 31, 2024 $65.83M
Current Assets Q1 2025 · Mar 31, 2025 $121.24M
Current Assets Q1 2025 · Dec 31, 2024 $131.53M
Total Assets Q1 2025 · Mar 31, 2025 $202.21M
Total Assets Q1 2025 · Dec 31, 2024 $226.24M
Shares Diluted Q1 2025 · Mar 31, 2024 8.02M sh
Capex Q1 2025 · Mar 31, 2024 $5.61M
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$21.89M
Stockholders Equity Q1 2025 · Mar 31, 2024 $151.36M
Stockholders Equity Q1 2025 · Dec 31, 2023 $169.91M
Eps Diluted Q1 2025 · Mar 31, 2024 −$2.44
Eps Basic Q1 2025 · Mar 31, 2024 −$2.44
Sga Expense Q1 2025 · Mar 31, 2024 $7.88M
Rd Expense Q1 2025 · Mar 31, 2024 $13.57M
Net Income Q1 2025 · Mar 31, 2024 −$19.56M
Operating Income Q1 2025 · Mar 31, 2024 −$21.45M